This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, H. Articles by Beaudet, A. L. Search for Related Content PubMed PubMed Citation Articles by Zhou, H. Articles by Beaudet, A. L.

 Previous Article  |  Next Article 

J. Virol., 10 1996, 7030-7038, Vol 70, No. 10
Copyright © 1996, American Society for Microbiology

Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted

H Zhou, W O'Neal, N Morral and AL Beaudet
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.

Although adenovirus vectors offer many advantages, it would be desirable to develop vectors with improved expression and decreased toxicity. Toward this objective, an adenovirus vector system with deletion of both the El and E2a regions was developed. A 5.9-kb fragment of the adenovirus type 5 (Ad5) genome containing the E2a gene and its early and late promoters was transfected into 293 cells. A complementing cell line, designated 293-C2, expressed the E2a mRNA and protein and was found to complement the defect in Ad5 viruses with temperature-sensitive or deletion mutations in E2a. A deletion of 1.3 kb removing codons 40 to 471 of the 529 amino acids of E2a was introduced into plasmids for preparation of viruses and vectors. An Ad5 virus with disruption of the El gene and deletion of E2a grew on 293-C2 cells but not on 293 cells. Vectors with E1 and E2a deleted expressing Escherichia coli beta-galactosidase or human alpha1-antitrypsin were prepared and expressed the reporter genes after intravenous injection into mice. This vector system retains sequences in common between the complementing cell line and the vectors, including 3.4 kb upstream and 1.1 kb downstream of the deletion. These vectors have potential advantages of increased capacity for insertion of transgene sequences, elimination of expression of E2a, and possibly reduction in expression of other viral proteins. Although the titers of the vectors with deleted are about 10- to 30-fold below those of vectors with E2a wild- type regions, the former vectors are suitable for detailed studies with animals to evaluate the effects on host immune responses, on duration of expression, and on safety.

This article has been cited by other articles:

• Zheng, X., Rao, X.-M., Gomez-Gutierrez, J. G., Hao, H., McMasters, K. M., Zhou, H. S. (2008). Adenovirus E1B55K Region Is Required To Enhance Cyclin E Expression for Efficient Viral DNA Replication. J. Virol. 82: 3415-3427 [Abstract] [Full Text]  
• Wang, H., Lieber, A. (2006). A Helper-Dependent Capsid-Modified Adenovirus Vector Expressing Adeno-Associated Virus Rep78 Mediates Site-Specific Integration of a 27-Kilobase Transgene Cassette. J. Virol. 80: 11699-11709 [Abstract] [Full Text]  
• Zhang, W., Low, J. A., Christensen, J. B., Imperiale, M. J. (2001). Role for the Adenovirus IVa2 Protein in Packaging of Viral DNA. J. Virol. 75: 10446-10454 [Abstract] [Full Text]  
• Morral, N., O'Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Cordova, E., Wadsworth, S., Graham, F. L., Kochanek, S., Carey, K. D., Beaudet, A. L. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA 96: 12816-12821 [Abstract] [Full Text]  
• Lee, B., Dennis, J. A., Healy, P. J., Mull, B., Pastore, L., Yu, H., Aguilar-Cordova, E., O'Brien, W., Reeds, P., Beaudet, A. L. (1999). Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia. Proc. Natl. Acad. Sci. USA 96: 3981-3986 [Abstract] [Full Text]  
• Lusky, M., Christ, M., Rittner, K., Dieterle, A., Dreyer, D., Mourot, B., Schultz, H., Stoeckel, F., Pavirani, A., Mehtali, M. (1998). In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted. J. Virol. 72: 2022-2032 [Abstract] [Full Text]  
• Baek, S., March, K. L. (1998). Gene Therapy for Restenosis : Getting Nearer the Heart of the Matter. Circ. Res. 82: 295-305 [Abstract] [Full Text]  
• Amalfitano, A., Hauser, M. A., Hu, H., Serra, D., Begy, C. R., Chamberlain, J. S. (1998). Production and Characterization of Improved Adenovirus Vectors with the E1, E2b, and E3 Genes Deleted. J. Virol. 72: 926-933 [Abstract] [Full Text]